Evonik Industries (EVK) Given a €31.00 Price Target by Independent Research Analysts

Evonik Industries (FRA:EVK) has been assigned a €31.00 ($36.05) target price by investment analysts at Independent Research in a research note issued on Wednesday. The firm presently has a “neutral” rating on the stock. Independent Research’s target price would indicate a potential upside of 12.24% from the stock’s previous close.

A number of other analysts also recently issued reports on EVK. Sanford C. Bernstein set a €36.00 ($41.86) price target on shares of Evonik Industries and gave the company a “buy” rating in a report on Tuesday. UBS Group set a €29.00 ($33.72) price objective on shares of Evonik Industries and gave the stock a “sell” rating in a research note on Tuesday. Societe Generale set a €40.00 ($46.51) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday. Commerzbank set a €39.00 ($45.35) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Wednesday, July 11th. Finally, equinet set a €41.00 ($47.67) price objective on shares of Evonik Industries and gave the stock a “buy” rating in a research note on Tuesday. Five research analysts have rated the stock with a sell rating, five have assigned a hold rating and twelve have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of €34.76 ($40.42).

Shares of FRA EVK opened at €27.62 ($32.12) on Wednesday. Evonik Industries has a 52-week low of €26.78 ($31.14) and a 52-week high of €32.97 ($38.34).

Evonik Industries Company Profile

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

Featured Article: Diversification Important in Investing

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply